These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26378253)

  • 1. Orchestration of ErbB3 signaling through heterointeractions and homointeractions.
    McCabe Pryor M; Steinkamp MP; Halasz AM; Chen Y; Yang S; Smith MS; Zahoransky-Kohalmi G; Swift M; Xu XP; Hanein D; Volkmann N; Lidke DS; Edwards JS; Wilson BS
    Mol Biol Cell; 2015 Nov; 26(22):4109-23. PubMed ID: 26378253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. erbB3 is an active tyrosine kinase capable of homo- and heterointeractions.
    Steinkamp MP; Low-Nam ST; Yang S; Lidke KA; Lidke DS; Wilson BS
    Mol Cell Biol; 2014 Mar; 34(6):965-77. PubMed ID: 24379439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.
    Zhang Q; Park E; Kani K; Landgraf R
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB Receptors and Cancer.
    Wang Z
    Methods Mol Biol; 2017; 1652():3-35. PubMed ID: 28791631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3.
    Sak MM; Szymanska M; Bertelsen V; Hasmann M; Madshus IH; Stang E
    Carcinogenesis; 2013 Sep; 34(9):2031-8. PubMed ID: 23698633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomers of ERBB3 have two distinct interfaces that differ in their sensitivity to disruption by heregulin.
    Kani K; Warren CM; Kaddis CS; Loo JA; Landgraf R
    J Biol Chem; 2005 Mar; 280(9):8238-47. PubMed ID: 15611073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.
    Mizutani K; Kedashiro S; Maruoka M; Ueda Y; Takai Y
    Sci Rep; 2017 Sep; 7(1):11375. PubMed ID: 28900130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flotillin depletion affects ErbB protein levels in different human breast cancer cells.
    Asp N; Pust S; Sandvig K
    Biochim Biophys Acta; 2014 Sep; 1843(9):1987-96. PubMed ID: 24747692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of erbB3 receptors in cancer therapeutic resistance.
    Lee Y; Ma J; Lyu H; Huang J; Kim A; Liu B
    Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):190-8. PubMed ID: 24449784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.
    Schoeberl B; Pace EA; Fitzgerald JB; Harms BD; Xu L; Nie L; Linggi B; Kalra A; Paragas V; Bukhalid R; Grantcharova V; Kohli N; West KA; Leszczyniecka M; Feldhaus MJ; Kudla AJ; Nielsen UB
    Sci Signal; 2009 Jun; 2(77):ra31. PubMed ID: 19567914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation.
    Kancha RK; von Bubnoff N; Duyster J
    Cell Commun Signal; 2013 Jun; 11():39. PubMed ID: 23758840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion.
    Yokoe S; Takahashi M; Asahi M; Lee SH; Li W; Osumi D; Miyoshi E; Taniguchi N
    Cancer Res; 2007 Mar; 67(5):1935-42. PubMed ID: 17332320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas.
    Alimandi M; Romano A; Curia MC; Muraro R; Fedi P; Aaronson SA; Di Fiore PP; Kraus MH
    Oncogene; 1995 May; 10(9):1813-21. PubMed ID: 7538656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.
    Lund CV; Popkov M; Magnenat L; Barbas CF
    Mol Cell Biol; 2005 Oct; 25(20):9082-91. PubMed ID: 16199884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.
    Black LE; Longo JF; Carroll SL
    Am J Pathol; 2019 Oct; 189(10):1898-1912. PubMed ID: 31351986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.